Financial Results, Corporate Restructuring, Dividends, and Court Proceedings - Research Reports on US Steel, CONSOL, NOV, Valero and Novo Nordisk

NEW YORK, October 31, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding United States Steel Corp. (NYSE: X), CONSOL Energy Inc. (NYSE: CNX), National Oilwell Varco, Inc. (NYSE: NOV), Valero Energy Corporation (NYSE: VLO) and Novo Nordisk A/S (NYSE: NVO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7615-100free.

--
United States Steel Corp. Research Reports
On October 28, 2014, United States Steel Corp. (US Steel) announced its Q3 2014 financial results with net sales up 11.0% YoY to $4.59 billion. The Company's net loss narrowed down to $207 million, or $1.42 per diluted share, compared to $1.8 billion in losses, or $12.38 per diluted share during Q3 2013. Earnings excluding items were $2.16 a share. Analysts polled by Thomson Reuters projected earnings of $1.17 a share on revenue of $4.56 billion. U.S. Steel President and CEO Mario Longhi said, "We experienced a significant improvement in Total reportable segments and Other Businesses income from operations in the third quarter, the highest level since the market peak in 2008. Steel market conditions in the U.S. have remained stable and our operations have performed well, particularly our Flat-rolled segment, where we returned to more normal operating levels and income from operations increased by over $300 million from the second quarter." In the trading session, following the results release, US Steel's stock gained 5.06% to end at $40.08. The full research reports on US Steel are available to download free of charge at:

http://www.analystsreview.com/Oct-31-2014/X/report.pdf

--
CONSOL Energy Inc. Research Reports
On October 28, 2014, CONSOL Energy Inc. (CONSOL) announced its Q3 2014 financial results. Total Revenue and Other Income stood at $884.6 million versus $803.3 million in Q3 2013.The Company's E&P Division achieved record production of 64.9 billions of cubic feet equivalent (Bcfe), compared with 46.1 Bcfe in Q3 2013. For the quarter, the Company reported net loss of $1.6 million or $0.01 per diluted share, versus a loss of $63.7 million or $0.28 per diluted share in Q3 2013. Adjusted profit of $0.09 per share, was below the average analyst estimate of $0.19, according to Thomson Reuters I/B/E/S. Commenting on the results, Nicholas J. DeIuliis, President and CEO said, "Our focus continues to be on execution: production growth, lowering costs, and maximizing rates of return. These factors, along with recent transactions such as the IPO of CONE Midstream Partners LP, will continue to drive CONSOL Energy's net asset value (NAV) per share growth." For full-year 2014, the Company increased its production guidance for E&P segment to 235 Bcfe - 240 Bcfe. The full research reports on CONSOL are available to download free of charge at:

http://www.analystsreview.com/Oct-31-2014/CNX/report.pdf

--
National Oilwell Varco, Inc. Research Reports
On October 17, 2014, National Oilwell Varco, Inc. (NOV) reported that the Company has been reorganized into three distinct business segments: NOV Rig Systems, NOV Wellbore Technologies, and NOV Completion & Production Solutions. The Company informed that the change was made to bring clarity to its strategic direction and to enhance National Oilwell's product and service offering. According to the Company, NOV Rig Systems creates and supports the world's most advanced drilling solutions; while NOV Wellbore Technologies integrates people, products, and technology to help our customers reach new levels of efficiency and productivity; and NOV Completion & Production Solutions helps its customers complete projects on target, delivering new levels of productivity. National Oilwell added that apart from the organizational restructuring, the Company has also simplified its website structure to clearly communicate the strengths of its business. The full research reports on NOV are available to download free of charge at:

http://www.analystsreview.com/Oct-31-2014/NOV/report.pdf

--
Valero Energy Corporation Research Reports
On October 23, 2014, Valero Energy Corporation (Valero) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.275 per share on its common stock. According to the Company, the dividend is payable on December 17, 2014 to holders of record at the close of business on November 19, 2014. The full research reports on Valero are available to download free of charge at:

http://www.analystsreview.com/Oct-31-2014/VLO/report.pdf

--
Novo Nordisk A/S Research Reports
On October 24, 2014, Novo Nordisk A/S (Novo Nordisk) reported that the Company has been served with a subpoena by the office of the US Attorney for the District of Massachusetts requesting documents regarding potential manufacturing issues within certain production units located in Kalundborg, Denmark. The Company informed that it is fully cooperating with the US Attorney in this investigation. Novo Nordisk added that it takes patient safety and product quality very seriously and is confident in the safety of its products. The full research reports on Novo Nordisk are available to download free of charge at:

http://www.analystsreview.com/Oct-31-2014/NVO/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review